RABL3
RABL3 (Rab-like protein 3) is an enzyme. The public catalogues list it as a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Pancreatic ductal adenocarcinoma.
Overview
Small GTPase required for KRAS signalling regulation and modulation of cell proliferation. Regulator of KRAS prenylation, and probably prenylation of other small GTPases. Required for lymphocyte development and function.
CIViC holds 1 clinical evidence item and 0 assertions across 1 variant. Open Targets scores its association with cancer at 0.60 (direct and indirect evidence; datatypes literature 0.46, genetic association 0.67, genetic literature 0.61).
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · RABL3 (Rab-like protein 3) is an enzyme. The public catalogues list it as a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Pancreatic ductal adenocarcinoma.
- 1 · What it is
RABL3 (Rab-like protein 3) is an enzyme. The public catalogues list it as a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Pancreatic ductal adenocarcinoma.
- 2 · What goes wrong in cancer
Small GTPase required for KRAS signalling regulation and modulation of cell proliferation. Regulator of KRAS prenylation, and probably prenylation of other small GTPases.
- 3 · How drugs use it
No product in this corpus aims at RABL3 yet. Inhibitors are shaped to fit the enzyme's active site so the reaction the cancer relies on stops.
External identifiers
Sources: HGNC HGNC:18072 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt Q5HYI8 (protein name, function text, keywords and locations (REST API)); CIViC gene RABL3 (1 evidence items, 0 assertions, 1 variants; diseases: Pancreatic Cancer (GraphQL API, CC0)); Open Targets ENSG00000144840 (association with cancer (MONDO_0004992) 0.60; (GraphQL API, CC0))
Biology
Small GTPase required for KRAS signalling regulation and modulation of cell proliferation. Regulator of KRAS prenylation, and probably prenylation of other small GTPases. Required for lymphocyte development and function. Not required for myeloid cell development. Interacts with Rab11 to promote ciliary vesicle formation at the mother centriole, thereby regulating early ciliogenesis. The GTP-binding capacity of RABL3 is essential for ciliogenesis. Location: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Golgi apparatus (UniProt). Locus 3q13.33 (HGNC).
- Pancreatic ductal adenocarcinoma: CIViC evidence names this disease
Notes
top- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: CIViC holds 1 clinical evidence items on its variants. Evidence tier "clinical-evidence" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
Latest papers
topQuery for this target: (TITLE:"RABL3" OR ABSTRACT:"RABL3" OR TITLE:"RAB, member of RAS oncogene family like 3" OR ABSTRACT:"RAB, member of RAS oncogene family like 3" OR TITLE:"Rab-like protein 3" OR ABSTRACT:"Rab-like protein 3" OR TITLE:"MGC23920" OR ABSTRACT:"MGC23920") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about RABL3, not a curated reading list.